Regarding the baseline characteristics, patients with available baseline HRQoL differed from other patients in terms of aspartate aminotransferase (P = 0.037), gamma‐glutamyl transpeptidase (P = 0.086) and cancer antigen 19‐9 (P = 0.039) (Table 1). The gene discussed is GGTLC1; the disease is cancer.